申请人:Applied Research Systems ARS Holding N.V.
公开号:EP1088822A1
公开(公告)日:2001-04-04
The present invention is related to sulfonyl hydrazide derivatives according to formula I
with its geometrical isomers, in an optically active form as enantiomers, diastereomers, as well as in the form of racemates, as well as pharmaceutically acceptable salts thereof, wherein
Ar1 and Ar2 are independently from each other an unsubstituted or substituted aryl or heteroaryl group,
X1 and X2 are independently from each other O or S;
R1, R2, R3 are independently from each other hydrogen or a C1-C6-alkyl substituent or R1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar1;
or R2 and R3 form a substituted or unsubstituted 5-6-membered saturated or unsaturated ring;
n is an integer from 0 to 5;
G is selected from a group comprising or consisting of an unsubstituted or substituted 4-8-membered heterocycle containing at least one heteroatom, or G is a substituted or unsubstituted C1-C6-alkyl group; for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonyl hydrazide derivatives. Said sulfonyl hydrazide derivatives are efficient modulators of the JNK pathway, they are in particular efficient inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonyl hydrazide derivatives as well as to methods of their preparation.
本发明涉及按照式I的磺酰基腙衍生物及其几何异构体,以对映体、二对映体的光学活性形式,以及它们的盐的药学上可接受的形式,其中Ar1和Ar2分别独立地是未取代或取代的芳基或杂环芳基,X1和X2分别独立地是O或S;R1、R2、R3分别独立地是氢或C1-C6-烷基取代基,或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环;或R2和R3形成取代或未取代的5-6元饱和或不饱和环;n是0到5的整数;G选自包含或仅包含至少一个杂原子的未取代或取代的4-8元杂环的群,或G是取代或未取代的C1-C6烷基基团;用作药学活性化合物,以及含有这种磺酰基腙衍生物的制药配方。所述磺酰基腙衍生物是JNK途径的高效调节剂,特别是JNK 2和3的高效抑制剂。本发明还涉及新型磺酰基腙衍生物以及其制备方法。